Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 30, 2026
Surveillance scrutinized: A critical look at screening for triple negative breast cancer recurrence
From the Parsons Lab, Clinical Research Division
Dr. Christopher Li shares vision for Public Health Sciences Division
‘We don’t want our work to just sit in academic journals, but to impact community’
‘Sweeping up the breadcrumbs’
Proton therapy using an innovative treatment approach helped a patient with breast cancer
Lobular community celebrates 10 years of progress, vows to ‘keep pedaling’
Patient advocates, clinicians and researchers gather for 2026 ILC Symposium; Fred Hutch joins LARC, new lobular research consortium
New assay better predicts treatment for two cancers
Fred Hutch researchers develop HRDefine, a new clinical test to better serve patients with tubo-ovarian and triple-negative breast cancer
Dr. Lynn Symonds receives ASCO Career Development Award
‘Homegrown’ Fred Hutch clinician-scholar honored for research on triple-negative breast cancer
Turning passion into progress: Thousands support groundbreaking research through Fred Hutch Obliteride
More than 6,400 cyclists, walkers, runners and volunteers brought commitment and joy to Fred Hutch’s annual bike ride, 5K walk/run and fundraiser
Speed dating? Shark Tank? Trainees promote their ideas for incorporating AI into their science
AI is enhancing research and care at Fred Hutch
Sidelining cancer treatment’s side effects through exercise, nutrition, prehab and rehab
In this episode of Bench to Bedside and Beyond, we talk to a prostate cancer survivor and the medical director of Fred Hutch’s cancer rehab about treatment’s aftermath
FDA approves new breast cancer drug based on VIKTORIA-1 study results
New targeted drug brings ‘big change, big benefit,’ per Fred Hutch’s Dr. Sara Hurvitz, who led the study
Beyond the 5-year myth: How survivorship care helps cancer patients live well
In this episode of From Bench to Bedside and Beyond, we discuss why Survivorship programs exist and how Fred Hutch’s program is changing to better serve patients
From treatment to thriving: Redefining cancer survivorship
In this episode of From Bench to Bedside and Beyond, we discuss how the growing field of survivorship supports patients as they navigate what's next
Dr. Nancy Davidson receives national cancer award
Fred Hutch leader accepts the David Karnofsky Science of Oncology Award, ASCO’s highest scientific honor and shares ‘lessons from the puzzle’ of endocrine therapy for early-stage hormone-responsive breast cancer
Un triplete de fármacos prolonga la supervivencia sin progresión en el cáncer de mama avanzado
Del equipo de oncología mamaria del Departamento de Investigaciones Clínicas y el grupo de estudio VIKTORIA-1
What cancer researchers, clinicians and patients say about ‘game-changing’ GLP-1s
Yes, you lose weight, but there are definitely trade-offs; cancer prevention role of new weight loss drugs still being studied
What inspires radiation oncologist Dr. Katarina Nguyen? People, science and music
Playing the zither created opportunities to empower the next generation of women